Prophylactic use of deferiprone (L1) and magnetic resonance imaging T2* or T2 for preventing heart disease in thalassaemia [1] (multiple letters)

Annita Kolnagou, Charis Fessas, Antonis Papatryphonas, Charalambos Economides, George J. Kontoghiorghes, Chaim Hershko, Maria D. Cappellini, Renzo Galanello, Antonio Piga, Gianni Tognoni, Giuseppe Masera

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)360-362
Number of pages3
JournalBritish Journal of Haematology
Volume127
Issue number3
DOIs
Publication statusPublished - Nov 2004

Keywords

  • Cardiomyopathy
  • Deferiprone
  • Iron toxicity
  • Magnetic resonance imaging T2 and T2*
  • Thalassaemia

ASJC Scopus subject areas

  • Hematology

Cite this